Caprock Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $3.46M | Buy |
10,002
+836
| +9% | +$289K | 0.11% | 171 |
|
|
2024
Q4 | $2.75M | Sell |
9,166
-1,425
| -13% | -$428K | 0.09% | 195 |
|
|
2024
Q3 | $4.3M | Sell |
10,591
-997
| -9% | -$405K | 0.16% | 105 |
|
|
2024
Q2 | $3.72M | Buy |
11,588
+7,327
| +172% | +$2.35M | 0.15% | 105 |
|
|
2024
Q1 | $1.42M | Buy |
4,261
+329
| +8% | +$110K | 0.08% | 189 |
|
|
2023
Q4 | $1.06M | Sell |
3,932
-128
| -3% | -$34.7K | 0.07% | 229 |
|
|
2023
Q3 | $999K | Buy |
4,060
+11
| +0.3% | +$2.71K | 0.08% | 208 |
|
|
2023
Q2 | $1.23M | Buy |
4,049
+262
| +7% | +$79.5K | 0.09% | 181 |
|
|
2023
Q1 | $999K | Buy |
3,787
+511
| +16% | +$135K | 0.08% | 200 |
|
|
2022
Q4 | $786K | Sell |
3,276
-495
| -13% | -$119K | 0.07% | 203 |
|
|
2022
Q3 | $693K | Buy |
3,771
+9
| +0.2% | +$1.65K | 0.07% | 213 |
|
|
2022
Q2 | $632K | Sell |
3,762
-265
| -7% | -$44.5K | 0.06% | 225 |
|
|
2022
Q1 | $1.01M | Buy |
4,027
+59
| +1% | +$14.8K | 0.09% | 171 |
|
|
2021
Q4 | $1.02M | Buy |
3,968
+1,166
| +42% | +$299K | 0.08% | 173 |
|
|
2021
Q3 | $680K | Buy |
2,802
+28
| +1% | +$6.8K | 0.06% | 213 |
|
|
2021
Q2 | $573K | Buy |
2,774
+48
| +2% | +$9.92K | 0.05% | 240 |
|
|
2021
Q1 | $513K | Sell |
2,726
-35
| -1% | -$6.59K | 0.06% | 233 |
|
|
2020
Q4 | $453K | Sell |
2,761
-2
| -0.1% | -$328 | 0.05% | 246 |
|
|
2020
Q3 | $344K | Buy |
+2,763
| New | +$344K | 0.05% | 265 |
|